IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Cologne | Germany
T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Cologne | Germany
T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de
IOZK presentation on the effects of multi-modal immunotherapy in a pontine glioma with the aid of liquid biopsy analysis
/in IOZK at conferences, Other announcements /by rootImmunotherapy for prostate cancer: Canadian research group presents the current situation
/in IOZK in the press, Other announcements /by IOZKBook published by Prof. Dr. Schirrmacher: Quo vadis cancer therapy
/in IOZK announcements, IOZK publications /by IOZKIOZK presentation by Stefaan Van Gool: Immunotherapy for diffuse intrinsic pontine glioma (DIPG), at the annual meeting of the Society for Neuro-Oncology (SNO) in San Francisco
/in IOZK announcements, IOZK at conferences /by IOZKIOZK publication in the International Journal of Molecular Sciences by Prof. Schirrmacher focusing on the role of Newcastle Disease Virus in tumor vaccinations
/in IOZK in the press, IOZK publications /by IOZKIOZK publication in Austin Oncology Case Reports on anti-tumor vaccines
/in IOZK in the press, IOZK publications /by IOZKArticle on pediatric neuro-oncologist Stefaan Van Gool in the Washington Post
/in IOZK in the press /by IOZKPublication by Prof Schirrmacher in Biomedicines: “Fifty Years of Clinical Application of Newcastle Disease Virus”
/in IOZK announcements, IOZK publications /by IOZK